Cancer Australia’s advisory group structure supports the agency’s purpose and its leadership role in national cancer control. Advisory group members represent a broad range of expertise, experiences and sectors, include consumer representation.
Cancer Australia values the advice and support extended to the organisation by the following strategic and project-specific Advisory Groups:
- Intercollegiate Advisory Group
- Leadership Group on Aboriginal and Torres Strait Islander Cancer Control
- Research and Data Advisory Group
- National Framework for Genomics in Cancer Control Expert Advisory Group
- National Framework for Genomics in Cancer Control Indigenous Governance Group
- National Cancer Expert Group
- National Data Steering Committee
- Australian Comprehensive Cancer Network Committee
Intercollegiate Advisory Group
The Intercollegiate Advisory Group provides expert advice to Cancer Australia across the spectrum of cancer control to: inform national approaches to reduce variations in cancer outcomes; promotes the use of best available evidence to achieve effective cancer care; identify collaborative approaches across the system to address cancer control challenges across the cancer care continuum from prevention to treatment; and provide advice on emerging issues nationally and internationally to inform Cancer Australia’s work.
The group is chaired by Professor Sandra O'Toole.
Leadership Group on Aboriginal and Torres Strait Islander Cancer Control
The Leadership Group on Aboriginal and Torres Strait Islander Cancer Control (Leadership Group) provides strategic advice and guidance to assist Cancer Australia and the Australian Government in Aboriginal and Torres Strait Islander cancer control. The Leadership Group: champions cross-sector collaboration in addressing and monitoring the progress of priorities in the Australian Cancer Plan and the National Aboriginal and Torres Strait Islander Cancer Framework; identifies and leverages opportunities to improve cancer outcomes at system, service and community levels; identifies emerging issues of national importance in Aboriginal and Torres Strait Islander cancer control and options to address these across multiple sectors; and provides input and advice in areas of specialised expertise.
The group is chaired by Associate Professor Lisa Whop.
Research and Data Advisory Group
The Research and Data Advisory Group provides expert advice to Cancer Australia on the strategic and priority areas of focus in cancer research and data including: work in research, clinical trials and data; strategies to strengthen and build on current programs of work in research, clinical trials and data; current and emerging issues in national and international cancer research, clinical trials and data; and research priorities, priorities for work in data, and key national and international partnerships and collaborations which support Cancer Australia’s leadership role in cancer research, clinical trials and data.
The group is chaired by Professor Raymond Chan.
National Framework for Genomics in Cancer Control Expert Advisory Group
The National Framework for Genomics in Cancer Control Expert Advisory Group provides high-level strategic and expert advice to Cancer Australia to guide the design and development of the National Framework for Genomics in Cancer Control. The Group identifies and advises on priority areas and emerging issues of relevance in cancer genomics across the cancer care continuum. They support engagement with the wider sector to ensure that outputs meet the needs of people affected by cancer and provide input and advice in areas of specialised expertise, as required.
The group is chaired by Professor Chris Karapetis.
National Framework for Genomics in Cancer Control Indigenous Governance Group
The National Framework for Genomics in Cancer Control Indigenous Governance Group provides expert advice on the approach to Aboriginal and Torres Strait Islander engagement for the Genomics Framework.
The group is chaired by Professor Dorothy Keefe PSM MD.
National Cancer Expert Group
The National Cancer Expert Group provides advice, guidance and expertise on cancer control matters of national interest to Cancer Australia. The Group provides strategic input on emerging jurisdictional trends and issues of national significance to cancer control in Australia and advice on priorities for cancer control in Australia from a national perspective. The Group supports implementation of the Australian Cancer Plan and on request, assists the Cancer and Population Screening Committee through Cancer Australia’s CEO.
The group is chaired by Professor Dorothy Keefe PSM MD.
National Data Steering Committee
The National Cancer Data Framework Steering Committee provides advice and guidance to Cancer Australia on the development of a national cancer data framework and minimum dataset to improve accessibility, consistency and comprehensiveness of integrated data assets. The Steering Committee provides expert strategic advice and guidance related to current gaps in Australia’s cancer data ecosystem, Framework governance and risk management, issues which may impact Framework development and implementation, implementation priorities and opportunities, and ways to monitor and report progress.
The group is chaired by Claire Howlett.
Australian Comprehensive Cancer Network Committee
The ACCN Committee, facilitated by Cancer Australia, provides advice to drive the development and expansion of the ACCN. The Committee advises on all policy and operational matters regarding the ACCN, to support the establishment of a fully integrated national network that connects cancer services across Australia to enable collaboration, sharing of expertise, and equitable access to comprehensive cancer care to all people affected by cancer in Australia.
The Committee is chaired by Professor Dorothy Keefe PSM MD.
